CSM(B) decided not to recommend action to stop continued importation of commercial concentrates. Read more about CSM(B) decided not to recommend action to stop continued importation of commercial concentrates.
The CSM endorsed the recommendation by the CSM(B) not to recommend action to stop continued importation of commercial concentrates. Read more about The CSM endorsed the recommendation by the CSM(B) not to recommend action to stop continued importation of commercial concentrates.
Paper from Dr Spence Galbraith recommended suspending importation of US blood products. Read more about Paper from Dr Spence Galbraith recommended suspending importation of US blood products.
FDA recommendation of steps including avoiding use of high risk plasma in US blood products was published. Read more about FDA recommendation of steps including avoiding use of high risk plasma in US blood products was published.
Licences for heat-treated Hemofil and Factorate were refused. Read more about Licences for heat-treated Hemofil and Factorate were refused.
The Department of Health and Social Security informed Immuno approval had been granted to vary the product licence in respect of Kryobulin to allow European plasma in be sold in red packs and US plasma to be sold in cheaper blue packs. Read more about The Department of Health and Social Security informed Immuno approval had been granted to vary the product licence in respect of Kryobulin to allow European plasma in be sold in red packs and US plasma to be sold in cheaper blue packs.
An application by Immuno to vary the product licence in respect of Kryobulin to allow European plasma to be sold in red packs and US plasma to be sold in cheaper blue packs was approved. Read more about An application by Immuno to vary the product licence in respect of Kryobulin to allow European plasma to be sold in red packs and US plasma to be sold in cheaper blue packs was approved.
An application was made by Immuno to vary the product licence in respect of Kryobulin to allow European plasma to be sold in red packs and US plasma to be sold in cheaper blue packs. Read more about An application was made by Immuno to vary the product licence in respect of Kryobulin to allow European plasma to be sold in red packs and US plasma to be sold in cheaper blue packs.
CSM recommended the grant of a product licence for Koate. Read more about CSM recommended the grant of a product licence for Koate.
Dr David Owen considered Armour's application to supply Factorate to haemophilia centres. Read more about Dr David Owen considered Armour's application to supply Factorate to haemophilia centres.